← Leaderboards
Brandon James Dekosky
University Of Kansas Lawrence
$9,036,847
Attributed
$13,978,623
Total exposure
8
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.2M · FY2016–25$5M$3.8M$2.5M$1.3M$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,978,623 · 8
By mechanism
U01$6,461,018 · 1
R01$3,062,685 · 2
DP5$2,206,861 · 1
R21$1,701,196 · 3
OT2$546,863 · 1
Top collaborators
- Priyamvada Acharya5 shared
- Alon Herschhorn5 shared
- Max Crispin4 shared
- Marcus Laird Forrest1 shared
- Lance Wells1 shared
Most similar at University Of Kansas Lawrence
Same institution · by research overlap
- Michael S Cohen$5,187,639
- Anthony Douglas Long$7,878,726
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularTechnologyAntibodiesSamplingVaccinesCellsInsightEpitopesB-LymphocytesBindingScreeningImmuneViralFutureImmune ResponseInfectionResponseCostDesignVaccine DesignVaccine DevelopmentYeastsPreventAntigens
Grant awards (26)
Dissecting the mechanisms of HIV resistance in vivo to broadly neutralizing antibodies$1,345,576
U01 · FY2025 · AI
Potent Antibody Protection Against P. falciparum and P. vivax Malaria$807,330
R01 · FY2025 · AI · contact PI
Potent broadly neutralizing antibody development against the HIV-1 fusion peptide epitope$755,855
R01 · FY2025 · AI · contact PI
MATCHMAKERS - Solving T-cell receptor recognition and design via integrated high-throughput screening and structural, functional and computational approaches$313,000
OT2 · FY2025 · CA · contact PI
Dissecting the mechanisms of HIV resistance in vivo to broadly neutralizing antibodies$1,522,830
U01 · FY2024 · AI
Potent broadly neutralizing antibody development against the HIV-1 fusion peptide epitope$757,390
R01 · FY2024 · AI · contact PI
Dissecting the mechanisms of HIV resistance in vivo to broadly neutralizing antibodies$535,920
U01 · FY2024 · AI
MATCHMAKERS - Solving T-cell receptor recognition and design via integrated high-throughput screening and structural, functional and computational approaches$233,863
OT2 · FY2024 · CA · contact PI
Dissecting the mechanisms of HIV resistance in vivo to broadly neutralizing antibodies$1,552,089
U01 · FY2023 · AI
Potent broadly neutralizing antibody development against the HIV-1 fusion peptide epitope$742,110
R01 · FY2023 · AI · contact PI
Rapid antibody screening systems to identify and engineer antiviral protection$366,403
R21 · FY2023 · AI · contact PI
Rapid antibody screening systems to identify and engineer antiviral protection$218,229
R21 · FY2023 · AI · contact PI
Dissecting the mechanisms of HIV resistance in vivo to broadly neutralizing antibodies$1,504,603
U01 · FY2022 · AI
Rapid antibody screening systems to identify and engineer antiviral protection$265,139
R21 · FY2022 · AI · contact PI
Antibody display libraries for precision screening of antibody immune responses to SARS-CoV-2$117,244
DP5 · FY2022 · OD · contact PI
Comprehensive analysis of human adaptive immune receptors to elucidate correlates of Epstein-Barr virus disease suppression$363,297
DP5 · FY2020 · OD · contact PI
Antibody display libraries for precision screening of antibody immune responses to SARS-CoV-2$259,300
DP5 · FY2020 · OD · contact PI
Comprehensive molecular and functional analyses of anti-HIV-1 broadly neutralizing antibody repertoires$192,025
R21 · FY2020 · AI
Probing antigen specificity and response of autoimmune B cells in Neuromyelitis Optica$189,375
R21 · FY2020 · AI · contact PI
Comprehensive analysis of human adaptive immune receptors to elucidate correlates of Epstein-Barr virus disease suppression$1
DP5 · FY2020 · OD · contact PI
Comprehensive analysis of human adaptive immune receptors to elucidate correlates of Epstein-Barr virus disease suppression$363,626
DP5 · FY2019 · OD · contact PI
Comprehensive molecular and functional analyses of anti-HIV-1 broadly neutralizing antibody repertoires$242,775
R21 · FY2019 · AI · contact PI
Probing antigen specificity and response of autoimmune B cells in Neuromyelitis Optica$227,250
R21 · FY2019 · AI · contact PI
Comprehensive analysis of human adaptive immune receptors to elucidate correlates of Epstein-Barr virus disease suppression$363,941
DP5 · FY2018 · OD · contact PI
Comprehensive analysis of human adaptive immune receptors to elucidate correlates of Epstein-Barr virus disease suppression$369,645
DP5 · FY2017 · OD · contact PI
Comprehensive analysis of human adaptive immune receptors to elucidate correlates of Epstein-Barr virus disease suppression$369,807
DP5 · FY2016 · OD · contact PI